Tag: Alveolar soft part sarcoma

Increased frailty associated with childhood cancer survivorship

Atezolizumab is a potentially effective treatment option for patients with alveolar soft part sarcoma

byKassandra McFarlaneand1 others

September 18, 2023

1. 37% of study patients had an objective response to treatment with atezolizumab. 2. Median progression-free survival was 20.8 months. ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

Tenecteplase and alteplase demonstrate similar efficacy for acute ischemic stroke
Switching from ticagrelor to clopidogrel may demonstrate benefit in patients with large body mass index and prior myocardial infarction
Cholecystectomy may be feasible in patients with silent common duct stones

No Result

View All Result